Digital Content 
NEWS #PharmaBuzz
07 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/07/3110902/0/en/BeyondSpring-Publishes-Human-Clinical-Study-in-Med-Cell-Press-Showing-Plinabulin-Driven-Dendritic-Cell-Maturation-and-Tumor-Response-After-Prior-Checkpoint-Inhibitor-Failure.html
03 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/03/3092584/0/en/BeyondSpring-Presents-Efficacy-Safety-Data-from-a-Phase-2-Study-of-Pembrolizumab-plus-Plinabulin-Docetaxel-in-Metastatic-NSCLC-after-Progressing-on-First-Line-Immune-Checkpoint-Inh.html
27 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/27/3050401/0/en/BeyondSpring-Reports-2024-Year-End-Financial-Results-and-Highlights-Key-Clinical-Strategic-Milestones.html
28 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/28/3016236/0/en/BeyondSpring-Announces-35-4-Million-Sale-of-a-Portion-of-Equity-Interest-in-SEED-Therapeutics-to-Advance-Lead-Asset-Plinabulin-to-Anti-Cancer-Registrational-Studies.html
11 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/11/2978241/0/en/BeyondSpring-Presents-Updated-Efficacy-Results-from-a-Phase-2-IIT-Study-of-Triple-IO-Combo-of-Pembrolizumab-plus-Plinabulin-Docetaxel-in-Metastatic-NSCLC-after-Progressing-on-Prior.html
16 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/16/2946478/0/en/BeyondSpring-Presents-Final-Data-Analysis-of-DUBLIN-3-Phase-3-Study-in-2L-3L-EGFR-Wild-type-NSCLC-at-ESMO-Congress-2024.html
Share 